icer white paper affordable access to glp-1 obesity medications 2025 A KFF analysis shows that use of and spending for drugs under Medicare grew substantially between 2019 and 2024, reflecting their effectiveness in treating type 2 diabetes and other conditions. Medicare Obesity Competitive Landscape Analysis 2026
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12


















:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)







